Last $8.86 USD
Change Today +0.07 / 0.80%
Volume 26.8K
VCYT On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 8:10 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

veracyte inc (VCYT) Snapshot

Open
$8.81
Previous Close
$8.79
Day High
$8.91
Day Low
$8.74
52 Week High
03/19/14 - $19.00
52 Week Low
11/14/14 - $6.01
Market Cap
199.4M
Average Volume 10 Days
42.9K
EPS TTM
$-1.42
Shares Outstanding
22.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VERACYTE INC (VCYT)

Related News

No related news articles were found.

veracyte inc (VCYT) Related Businessweek News

No Related Businessweek News Found

veracyte inc (VCYT) Details

Veracyte, Inc. operates as a diagnostics company in the field of molecular cytology to enhance patient outcomes and lower healthcare costs. It provides Afirma Thyroid FNA Analysis, a solution that consists of its Gene Expression Classifier, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. The company is also developing Afirma Malignancy Classifiers for rare forms of thyroid cancer or metastases to the thyroid that is intended to inform surgical strategy; and idiopathic pulmonary fibrosis and nodules suspicious products for lung cancer. It serves endocrinologists, radiologists, and head and neck specialists. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

115 Employees
Last Reported Date: 03/20/14
Founded in 2006

veracyte inc (VCYT) Top Compensated Officers

Co-Founder, Chief Executive Officer, Presiden...
Total Annual Compensation: $380.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $201.0K
Chief Operating Officer
Total Annual Compensation: $316.3K
Compensation as of Fiscal Year 2013.

veracyte inc (VCYT) Key Developments

Veracyte, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-02-2015 04:50 PM

Veracyte, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-02-2015 04:50 PM. Venue: The Boston Marriott Copley Place, Boston, Massachusetts, United States. Speakers: Bonnie H. Anderson, Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee.

Veracyte, Inc. Presents at Leerink's Global Healthcare Conference, Feb-11-2015 11:30 AM

Veracyte, Inc. Presents at Leerink's Global Healthcare Conference, Feb-11-2015 11:30 AM. Venue: Waldorf Astoria New York, New York, New York, United States. Speakers: Bonnie H. Anderson, Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee.

Veracyte, Inc. Names Dr. Robert S. Epstein to its Board of Directors

Veracyte, Inc. announced the appointment of Robert S. Epstein, M.D., M.S., to its Board of Directors. Dr. Epstein is a strategic consultant to life sciences companies and an epidemiologist with extensive expertise in pharmacoeconomics and health outcomes research, having held various positions in academia and public health before joining the private sector. Dr. Epstein is the former president of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), and served on the Board of Directors of the Drug Information Association (DIA) and the International Society of Quality of Life. He has also served on the federal CDC EGAPP (Evaluation of Genomic Applications in Practice & Prevention) Stakeholder Committee and the AHRQ CERTs (Centers for Education and Research on Therapeutics) Committee. In addition to Veracyte, Dr. Epstein serves on the Board of Directors of Illumina, Inc., Proteus Digital Health, Inc. and Fate Therapeutics, Inc.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VCYT:US $8.86 USD +0.07

VCYT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Genomic Health Inc $31.10 USD +0.70
Laboratory Corp of America Holdings $123.36 USD +0.33
Response Genetics Inc $0.57 USD -0.0544
Rosetta Genomics Ltd $3.47 USD +0.06
Trovagene Inc $6.05 USD +0.40
View Industry Companies
 

Industry Analysis

VCYT

Industry Average

Valuation VCYT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.8x
Price/Book 4.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERACYTE INC, please visit www.veracyte.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.